The European Commission is slated to rule by July 9 on the latest in a series of consolidation deals in the globe’s pharmaceutical industry.

According to reports, the Commission is set to decide on whether to approve of Zimmer Holding’s offer for Biomet; the US-based orthopedic product maker submitted a bid …read more

Source: Global Competition Law Blogs